Blink Health, an app that helps people save money on prescription medications, raises $90M Series B led by 8VC, bringing total raised to $165M
Lydia Ramsey / Business Insider :
Context & Ripple Effects
The raise, first reported two days earlier, puts $90M behind Blink Health's model of letting consumers pay discounted cash prices for prescriptions through an app rather than navigating insurance pricing — with 8VC leading and total funding now at $165M.
It lands in a cluster of venture bets on software that restructures how medications reach patients: Xealth is building provider-side tooling for prescribing non-drug services like apps and monitors, while BrightInsight's $101M Series C funds patient- and doctor-facing apps built for drug and device makers.
First-order effects
- Blink Health exits the round with $165M raised and an 8VC-led cap table, giving it capital to scale its consumer prescription-discount app against whatever marketing spend the category demands.
Second-order effects
- The round validates prescription-software as a fundable category on both sides of the transaction — Blink Health on the consumer pricing side, Xealth and BrightInsight on the provider and manufacturer side — sharpening the pitch each will make to the same healthcare buyers.
Third-order effects
- If discounting apps like Blink Health keep absorbing capital, the price-comparison layer between patients and pharmacies becomes its own contested position in drug distribution, separate from insurers and pharmacy benefit managers.
The trend: Prescription access is being rebuilt as consumer and provider software, with venture rounds increasingly funding the intermediaries that sit between patients and drug prices.